Abstract
This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.
Publication types
- Research Support, Non-U.S. Gov't
MeSH terms
- Adult
- Aged
- Asymptomatic Infections / epidemiology
- BNT162 Vaccine
- COVID-19 / diagnosis
- COVID-19 / epidemiology*
- COVID-19 / prevention & control
- COVID-19 Vaccines*
- Female
- Humans
- Male
- Mass Screening
- Middle Aged
- Personnel, Hospital*
- Retrospective Studies
Substances
- COVID-19 Vaccines
- BNT162 Vaccine